| abstract |
Incorporation of costimulatory signaling domains within tumor targeting chimeric antigen receptors (CARs) such as IL13Rα2-specific IL13-zetakine (IL13ζ) was in the absence of expressed ligands for costimulatory receptors. Even enhance T cell-mediated responses to tumors. [Selection figure] None |